{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:12:46Z","timestamp":1780657966025,"version":"3.54.1"},"reference-count":192,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jgyn.2016.09.033","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T23:00:59Z","timestamp":1478214059000},"page":"1490-1514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Interruption volontaire de grossesse par voie m\u00e9dicamenteuse"],"prefix":"10.1016","volume":"45","author":[{"given":"K.","family":"Bettahar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Boisram\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Cavillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wylomanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Nisand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2016.09.033_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/jcem-60-1-156","article-title":"Endometrial and pituitary responses to the steroidal antiprogestin RU 486\u00a0in postmenopausal women","volume":"60","author":"Gravanis","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1471-0528.1988.tb06840.x","article-title":"The effect of the antiprogestin RU 486\u00a0on uterine contractility and sensitivity to prostaglandin and oxytocin","volume":"95","author":"Swahn","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0015","unstructured":"IVG m\u00e9thode m\u00e9dicamenteuse\u00a0\u2013\u00a0Argumentaire\u00a0\u2013\u00a0MEL\u00a0\u2013\u00a0ivg_methode_medicamenteuse_-_recommandations_-_mel_2011-04-28_11-39-11_882.pdf."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jgyn.2013.11.007","article-title":"[Misoprostol\u00a0: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)]","volume":"43","author":"Beucher","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0025","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.2781282","article-title":"Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor","volume":"245","author":"Baulieu","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0030","first-page":"248","article-title":"Antiprogestatifs\u00a0\u2013\u00a0m\u00e9canisme d\u2019action","volume":"12","author":"Guiochon-Mantel","year":"1999","journal-title":"Reprod Hum Horm"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0010-7824(93)90133-R","article-title":"Clinical pharmacology of RU 486\u00a0\u2013\u00a0an antiprogestin and antiglucocorticoid","volume":"48","author":"Spitz","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0040","first-page":"CD007207","article-title":"Cervical preparation for first trimester surgical abortion","author":"Kapp","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/07853899309147861","article-title":"Dose-response relationships of RU 486","volume":"25","author":"Heikinheimo","year":"1993","journal-title":"Ann Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(85)90115-5","article-title":"Progesterone receptor blockage. Effect on uterine contractility and early pregnancy","volume":"32","author":"Bygdeman","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369\u00a0women","volume":"71","author":"Ulmann","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0065","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ijgo.2007.09.004","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0070","first-page":"1","article-title":"A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes","author":"Frye","year":"2016","journal-title":"Eur J Contracept Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0080","first-page":"198","article-title":"Methotrexate and misoprostol for early abortion","volume":"28","author":"Schaff","year":"1996","journal-title":"Fam Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0085","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1067\/mob.2000.107949","article-title":"Alternatives to mifepristone regimens for medical abortion","volume":"183","author":"Pymar","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(99)00115-8","article-title":"The efficacy of medical abortion: a meta-analysis","volume":"61","author":"Kahn","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0010-7824(92)90001-A","article-title":"Clinical trial on termination of early pregnancy with RU486\u00a0in combination with prostaglandin","volume":"46","author":"Wu","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0015-0282(16)56637-0","article-title":"Analysis of 369\u00a0abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center","volume":"61","author":"Thonneau","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0105","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/HUMREP\/10.6.1521","article-title":"Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion","volume":"10","author":"Baird","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9378(97)70511-8","article-title":"Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion","volume":"176","author":"Winikoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0115","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/humrep\/13.10.2962","article-title":"An effective regimen for early medical abortion: a report of 2000\u00a0consecutive cases","volume":"13","author":"Ashok","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(02)00366-9","article-title":"Randomized trial of oral versus vaginal misoprostol 2\u00a0days after mifepristone 200mg for abortion up to 63\u00a0days of pregnancy","volume":"66","author":"Schaff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.AOG.0000152003.94320.59","article-title":"Multicenter trial of a simplified mifepristone medical abortion regimen","volume":"105","author":"Shannon","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0130","first-page":"CD002855","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0135","first-page":"CD002253","article-title":"Medical treatment for early fetal death (less than 24\u00a0weeks)","author":"Neilson","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0140","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bmj.307.6903.532","article-title":"Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation","volume":"307","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0145","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","volume":"107","year":"2000","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.contraception.2009.01.011","article-title":"Meta-analysis of 200\u00a0or 600mg mifepristone in association with two prostaglandins for termination of early pregnancy","volume":"80","author":"Li\u00e8vre","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0155","unstructured":"The care of women requesting induced abortion (Evidence-based Clinical Guideline No.\u00a07). R Coll Obstet Amp Gynaecol."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0160","unstructured":"WHO. Safe abortion: technical and policy guidance for health systems. WHO."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0165","unstructured":"International Planned Parenthood Federation. First Trimester Abortion Guidelines and Protocols. Int Plan Parent Fed."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0170","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/01.AOG.0000444454.67279.7d","article-title":"Practice bulletin no\u00a0143. Medical management of first-trimester abortion","volume":"123","author":"American College of Obstetricians and Gynecologists","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-0528.2008.02034.x","article-title":"Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial","volume":"116","author":"von Hertzen","year":"2009","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0180","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1933719114557897","article-title":"Effectiveness and safety of lower doses of mifepristone combined with misoprostol for the termination of ultra-early pregnancy: a dose-ranging randomized controlled trial","volume":"22","author":"Li","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0185","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24hours apart for abortion: a randomized controlled trial","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0190","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","article-title":"A randomized comparison of misoprostol 6\u00a0to 8hours versus 24hours after mifepristone for abortion","volume":"103","author":"Creinin","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0195","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0200","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":"Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial","volume":"117","author":"von Hertzen","year":"2010","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0205","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00404-015-3722-1","article-title":"Early versus late misoprostol administration after mifepristone for medical abortion","volume":"292","author":"Tendler","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijgo.2013.08.009","article-title":"Dosing interval of 24hours versus 48hours between mifepristone and misoprostol administration for mid-trimester termination of pregnancy","volume":"124","author":"Chaudhuri","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0215","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/AOG.0b013e3182932f37","article-title":"Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review","volume":"121","author":"Shaw","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2009.09.007","article-title":"Flexible mifepristone and misoprostol administration interval for first-trimester medical termination","volume":"81","author":"Wedisinghe","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.contraception.2006.03.014","article-title":"Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion","volume":"74","author":"Schaff","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijgo.2012.12.009","article-title":"WHO recommendations for misoprostol use for obstetric and gynecologic indications","volume":"121","author":"Tang","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.07.013","article-title":"FIGO Working Group on Prevention of Unsafe Abortion and its Consequences. International Federation of Gynecology and Obstetrics. The combination of mifepristone and misoprostol for the termination of pregnancy","volume":"115","author":"Fa\u00fandes","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bpobgyn.2010.02.006","article-title":"Medical and surgical options for induced abortion in first trimester","volume":"24","author":"Hamoda","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0250","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tjog.2014.07.010","article-title":"The combination route versus sublingual and vaginal misoprostol for the termination of 13\u00a0to 24\u00a0week pregnancies: a randomized clinical trial","volume":"54","author":"Rahimi-Sharbaf","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0255","series-title":"Safe Abortion: Technical and Policy Guidance for Health Systems","year":"2012"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0260","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jogc.2016.01.002","article-title":"Medical abortion","volume":"38","author":"Costescu","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejogrb.2015.01.018","article-title":"Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Coll\u00e8ge national des gyn\u00e9cologues obst\u00e9triciens fran\u00e7ais","volume":"187","author":"Marret","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2015.01.005","article-title":"Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63\u00a0days","volume":"91","author":"Gatter","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0280","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0285","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199305273282101","article-title":"Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol","volume":"328","author":"Peyron","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0290","first-page":"85","article-title":"Termination of early pregnancy (up to 63\u00a0days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected]","volume":"40","author":"Aub\u00e9ny","year":"1995","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0295","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9378(99)70386-8","article-title":"Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion","volume":"181","author":"Creinin","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0300","series-title":"Interruption volontaire de grossesse par m\u00e9thode m\u00e9dicamenteuse. Recommandations de bonne pratique","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2010"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0305","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.contraception.2011.12.012","article-title":"A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion","volume":"86","author":"Chong","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0310","doi-asserted-by":"crossref","first-page":"462","DOI":"10.12809\/hkmj154525","article-title":"First-trimester medical abortion service in Hong Kong","author":"Lo","year":"2015","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0315","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijgo.2014.09.022","article-title":"A prospective open-label study of home use of mifepristone for medical abortion in Nepal","volume":"128","author":"Conkling","year":"2015","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0320","unstructured":"Haute Autorit\u00e9 de sant\u00e9. MisoOne 400\u03bcg (misoprostol), prostaglandine ocytocique."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.gyobfe.2005.02.021","article-title":"[The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433\u00a0patients]","volume":"33","author":"Faucher","year":"2005","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0330","first-page":"111","article-title":"Buccal versus vaginal misoprostol administration for the induction of first and second trimester abortions","volume":"65","author":"Garg","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0335","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70\u00a0days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0968-8080(15)43825-X","article-title":"Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70\u00a0days since last menstrual period in public sector facilities in Mexico City","volume":"22","author":"Sanhueza Smith","year":"2015","journal-title":"Reprod Health Matt"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.contraception.2013.10.018","article-title":"A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70\u00a0days\u2019 LMP: a prospective comparative open-label trial","volume":"89","author":"Bracken","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2015.06.018","article-title":"Outpatient medical abortion is safe and effective through 70\u00a0days gestation","volume":"92","author":"Abbas","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0355","first-page":"505","article-title":"[Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8\u00a0and 16\u00a0weeks of gestation]","volume":"50","author":"Qian","year":"2015","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.contraception.2003.09.006","article-title":"Midtrimester medical termination of pregnancy: a review of 1002\u00a0consecutive cases","volume":"69","author":"Ashok","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0365","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(05)79250-3","article-title":"Termination of pregnancy at 9\u201313\u00a0weeks\u2019 amenorrhoea with mifepristone and misoprostol","volume":"352","author":"Ashok","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0370","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.0001-6349.2005.00728.x","article-title":"Psychological sequelae of medical and surgical abortion at 10\u201313weeks gestation","volume":"84","author":"Ashok","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0375","doi-asserted-by":"crossref","first-page":"f7553","DOI":"10.1136\/bmj.f7553","article-title":"Abortion","volume":"348","author":"Lohr","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0380","first-page":"CD005216","article-title":"Medical methods for mid-trimester termination of pregnancy","author":"Wildschut","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0385","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0968-8080(15)43824-8","article-title":"The introduction of first trimester medical abortion in Armenia","volume":"22","author":"Louie","year":"2015","journal-title":"Reprod Health Matt"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0390","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/13625187.2014.933956","article-title":"Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan","volume":"19","author":"Louie","year":"2014","journal-title":"Eur J Contracept Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0395","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijgo.2014.09.022","article-title":"A prospective open-label study of home use of mifepristone for medical abortion in Nepal","volume":"128","author":"Conkling","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0400","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2012.10.021","article-title":"Acceptability of home use of mifepristone for medical abortion","volume":"88","author":"Swica","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0405","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2015.06.026","article-title":"A prospective, non-randomized study of home use of mifepristone for medical abortion in the US","volume":"92","author":"Chong","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0410","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.contraception.2015.06.011","article-title":"If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion","volume":"92","author":"Gold","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0415","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0420","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2015.08.010","article-title":"Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol","volume":"93","author":"Reeves","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0425","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/humrep\/16.10.2098","article-title":"Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63\u00a0days gestation","volume":"16","author":"Bartley","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0430","unstructured":"Vidal.fr\u00a0\u2013\u00a0La base de donn\u00e9es en ligne des prescripteurs lib\u00e9raux."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0435","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. MIFFEE (mif\u00e9pristone), antiprogestatif."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0440","first-page":"813","article-title":"Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol","volume":"99","author":"Wiebe","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0445","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0b013e3182073fbf","article-title":"Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial","volume":"117","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0450","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.contraception.2012.05.009","article-title":"A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63\u00a0days","volume":"86","author":"Yeung","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0455","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejogrb.2014.10.025","article-title":"Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study","volume":"184","author":"Nisand","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0460","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.contraception.2004.04.009","article-title":"Infection after medical abortion: a review of the literature","volume":"70","author":"Shannon","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0465","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.AOG.0000287291.19230.ba","article-title":"Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion","volume":"110","author":"Cohen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0470","doi-asserted-by":"crossref","first-page":"459e1","DOI":"10.1016\/j.ajog.2009.05.023","article-title":"Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age","volume":"201","author":"Ho","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0475","series-title":"National abortion federation clinical policy guidelines","author":"Reeves","year":"2015"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0480","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1479-828X.2012.01460.x","article-title":"Antibiotic prophylaxis in obstetric and gynaecological procedures: a review","volume":"52","author":"Clifford","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0485","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion","volume":"361","author":"Fjerstad","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgo.2015.11.028","article-title":"Updated French guidelines for diagnosis and management of pelvic inflammatory disease","author":"Brun","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0495","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00007435-200102000-00011","article-title":"Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study","volume":"28","author":"Whittington","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0500","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1471-0528.2002.01009.x","article-title":"Universal prophylaxis compared with screen-and-treat for Chlamydia trachomatis prior to termination of pregnancy","volume":"109","author":"Cameron","year":"2002","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0505","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/13625187.2014.950730","article-title":"Pain during medical abortion, the impact of the regimen: a neglected issue? A review","volume":"19","author":"Fiala","year":"2014","journal-title":"Eur J Contracept Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0510","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/AOG.0b013e31829d5a33","article-title":"Prophylactic compared with therapeutic ibuprofen analgesia in first-trimester medical abortion: a randomized controlled trial","volume":"122","author":"Raymond","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0515","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00000542-200112000-00013","article-title":"The visual analog scale for pain: clinical significance in postoperative patients","volume":"95","author":"Bodian","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0520","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/ajem.2002.33778","article-title":"Reliability and validity of a visual analog scale for acute abdominal pain in the ED","volume":"20","author":"Gallagher","year":"2002","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0525","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejogrb.2015.09.025","article-title":"Pain during medical abortion: a multicenter study in France","volume":"194","author":"Saurel-Cubizolles","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0530","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.contraception.2010.08.006","article-title":"Pain during medical abortion: predicting factors from gynecologic history and medical staff evaluation of severity","volume":"83","author":"Suhonen","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0535","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(00)00090-1","article-title":"Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group","volume":"61","author":"Westhoff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0540","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","article-title":"Factors affecting the outcome of early medical abortion: a review of 4132\u00a0consecutive cases","volume":"109","author":"Ashok","year":"2002","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0545","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(00)00186-4","article-title":"Analgesia during at-home use of misoprostol as part of a medical abortion regimen","volume":"62","author":"Westhoffa","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0550","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.contraception.2010.07.014","article-title":"Pain control in first-trimester and second-trimester medical termination of pregnancy: a systematic review","volume":"83","author":"Jackson","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0555","unstructured":"Induced abortion guidelines\u00a0\u2013\u00a0gui184E0611.pdf."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0560","unstructured":"2015_NAF_CPGs.pdf."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0565","unstructured":"3270\u00a0RCOG Abortion guideline.qxd\u00a0\u2013\u00a0abortion-guideline_web_1.pdf."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0570","unstructured":"Recommendation.pmd\u00a0\u2013\u00a0jaqt11i1p90.pdf."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0575","unstructured":"9789241 548434_eng.pdf."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0580","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.fertnstert.2008.01.084","article-title":"Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study","volume":"91","author":"Livshits","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0585","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.fertnstert.2011.12.041","article-title":"Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study","volume":"97","author":"Avraham","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0590","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00120-0","article-title":"Effect of non-steroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion","volume":"56","author":"Creinin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0595","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0020-7292(01)00453-2","article-title":"Pain control in medical abortion","volume":"74","author":"Wiebe","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0600","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/BF03018370","article-title":"Patient-controlled analgesia with fentanyl provides effective analgesia for second trimester labour: a randomized controlled study","volume":"50","author":"Castro","year":"2003","journal-title":"Can J Anaesth J Can Anesth"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0605","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.contraception.2009.07.009","article-title":"The effect of phloroglucinol on pain in first-trimester surgical abortion: a double-blind randomized controlled study","volume":"81","author":"Zhuang","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0610","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/OGX.0000000000000272","article-title":"Pain management for gynecologic procedures in the office","volume":"71","author":"Ireland","year":"2016","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0615","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/oxfordjournals.humrep.a138582","article-title":"Incidence of ectopic pregnancy. First results of a population-based register in France","volume":"9","author":"Coste","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0620","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.contraception.2012.10.013","article-title":"Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sac","volume":"87","author":"Goldstone","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0625","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(01)00200-1","article-title":"Mifepristone and misoprostol for early abortion when no gestational sac is present","volume":"63","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0630","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.gyobfe.2003.12.011","article-title":"[Recommendations for clinical practice: management of extra-uterine pregnancy]","volume":"32","author":"Goffinet","year":"2004","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0635","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.contraception.2014.01.016","article-title":"Medical management of first-trimester abortion","volume":"89","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0640","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/HUMREP\/10.6.1512","article-title":"A comparative analysis of fall in haemoglobin following abortions conducted by mifepristone (600mg) and vacuum aspiration","volume":"10","author":"Thonneau","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0645","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0010-7824(03)00049-0","article-title":"Mifepristone and misoprostol for early medical abortion: 18\u00a0months experience in the United States","volume":"67","author":"Hausknecht","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0650","unstructured":"Revue Prescrire\u00a0\u2013\u00a0Sommaire du no\u00a0376\u00a0f\u00e9vrier 2015."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0655","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.ajog.2004.05.008","article-title":"Misoprostol versus methylergometrine: pharmacokinetics in human milk","volume":"191","author":"Vogel","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0660","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/00016341003721037","article-title":"Medical abortion in lactating women\u00a0\u2013\u00a0low levels of mifepristone in breast milk","volume":"89","author":"S\u00e4\u00e4v","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0665","unstructured":"CRAT\u00a0\u2013\u00a0Centre de r\u00e9f\u00e9rence sur les agents t\u00e9ratog\u00e8nes chez la femme enceinte."},{"key":"10.1016\/j.jgyn.2016.09.033_bib0670","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.contraception.2011.02.015","article-title":"Outcomes of medical abortion through 63\u00a0days in women with twin gestations","volume":"84","author":"Hayes","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0675","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ajog.2008.10.016","article-title":"Relationship of obesity to outcome of medical abortion","volume":"200","author":"Strafford","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0680","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/AOG.0b013e31819dbfe2","article-title":"Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review","volume":"113","author":"Goyal","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0685","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1471-0528.2009.02190.x","article-title":"Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review","volume":"116","author":"Berghella","year":"2009","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0690","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-7824(00)00187-6","article-title":"Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161\u00a0consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost","volume":"62","author":"Bartley","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0695","first-page":"802389","article-title":"Bolstering the evidence base for integrating abortion and HIV care: a literature review","volume":"2012","author":"Manski","year":"2012","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0700","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2006.11.011","article-title":"Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0705","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/17455057.4.2.107","article-title":"How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?","volume":"4","author":"Shannon","year":"2008","journal-title":"Womens Health Lond Engl"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0710","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2009.08.008","article-title":"Feasibility of telephone follow-up after medical abortion","volume":"81","author":"Perriera","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0715","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.contraception.2014.01.010","article-title":"Simplified follow-up after early medical abortion: 12-month experience of a telephone call and self-performed low-sensitivity urine pregnancy test","volume":"89","author":"Michie","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0720","series-title":"IVG m\u00e9dicamenteuse","author":"Faucher","year":"2005"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0725","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/01443610600830946","article-title":"Isolated one-sided cerebellar agenesis following an attempted medical termination of pregnancy","volume":"26","author":"Afadapa","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0730","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1471-0528.12147","article-title":"Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study","volume":"120","author":"Bernard","year":"2013","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0735","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJM199806253382604","article-title":"Use of misoprostol during pregnancy and M\u00f6bius\u2019 syndrome in infants","volume":"338","author":"Pastuszak","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0740","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0140-6736(91)93212-R","article-title":"Brazil: misuse of misoprostol as an abortifacient may induce malformations","volume":"337","author":"Sch\u00f6nh\u00f6far","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0745","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(97)12363-7","article-title":"Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy","volume":"351","author":"Gonzalez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0750","first-page":"147","article-title":"[Moebius syndrome due to the use of misoprostol. Case report]","volume":"44","author":"S\u00e1nchez","year":"2003","journal-title":"Invest Clin"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0755","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1345\/aph.1K550","article-title":"M\u00f6bius syndrome in a neonate after mifepristone and misoprostol elective abortion failure","volume":"42","author":"Bos-Thompson","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0760","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.reprotox.2012.11.009","article-title":"Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study","volume":"36","author":"Vauzelle","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0765","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-0528.2004.00153.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion","volume":"111","author":"Honkanen","year":"2004","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0770","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(00)00181-5","article-title":"Timing of pain and bleeding after mifepristone-induced abortion","volume":"62","author":"De Nonno","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0775","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol","volume":"332","author":"el-Refaey","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0780","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1067\/mob.2000.107946","article-title":"Management of side effects and complications in medical abortion","volume":"183","author":"Kruse","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0785","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2012.09.022","article-title":"A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63\u00a0days\u2019 gestation","volume":"87","author":"Chai","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0790","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2008.09.001","article-title":"Two-pill regimens of misoprostol after mifepristone medical abortion through 63\u00a0days\u2019 gestational age: a randomized controlled trial of sublingual and oral misoprostol","volume":"79","author":"Raghavan","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0795","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00404-010-1590-2","article-title":"Randomized trial of oral versus sublingual misoprostol 24h after mifepristone for medical abortion","volume":"284","author":"Dahiya","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0800","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.contraception.2011.05.019","article-title":"Can women accurately assess the outcome of medical abortion based on symptoms alone?","volume":"85","author":"Jackson","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0805","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2004.04.005","article-title":"Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion","volume":"70","author":"Rossi","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0810","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a routine follow-up visit for early medical abortion","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0815","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.contraception.2006.08.001","article-title":"Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0820","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2010.08.023","article-title":"Alternatives to ultrasound for follow-up after medication abortion: a systematic review","volume":"83","author":"Grossman","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0825","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/AOG.0b013e3182839fda","article-title":"Medical abortion follow-up with serum human chorionic gonadotropin compared with ultrasonography: a randomized controlled trial","volume":"121","author":"Dayananda","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0830","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0301-2115(03)00012-5","article-title":"Verifying the effectiveness of medical abortion; ultrasound versus hCG testing","volume":"109","author":"Fiala","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0835","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0010-7824(02)00316-5","article-title":"Clinicians\u2019 perception of sonogram indication for mifepristone abortion up to 63\u00a0days","volume":"66","author":"Fielding","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0840","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2011.09.007","article-title":"Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment","volume":"85","author":"Horning","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0845","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/17.9.2315","article-title":"The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy","volume":"17","author":"Honkanen","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0850","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/13625180701536300","article-title":"Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness","volume":"12","author":"Parashar","year":"2007","journal-title":"Eur J Contracept Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0855","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.contraception.2007.04.008","article-title":"Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: a possible screening tool for ongoing pregnancy after medication abortion","volume":"76","author":"Grossman","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0860","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.fertnstert.2004.10.038","article-title":"Secretion and excretion of human chorionic gonadotropin during early pregnancy","volume":"83","author":"Lohstroh","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0865","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.contraception.2012.06.005","article-title":"Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study","volume":"86","author":"Blum","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0870","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2007.01.021","article-title":"Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited","volume":"75","author":"Godfrey","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0875","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2011.11.010","article-title":"Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation","volume":"86","author":"Cameron","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0880","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S2214-109X(15)00150-3","article-title":"Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial","volume":"3","author":"Iyengar","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0885","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejogrb.2015.11.013","article-title":"Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion","volume":"197","author":"Hassoun","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0890","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.1994.03520150058037","article-title":"Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial","volume":"272","author":"Creinin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0895","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0900","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0010-7824(99)00105-5","article-title":"A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination","volume":"60","author":"Jain","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0905","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0010-7824(99)00047-5","article-title":"Methotrexate and misoprostol used alone or in combination for early abortion","volume":"59","author":"Ozeren","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0910","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/oxfordjournals.humrep.a138287","article-title":"The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol","volume":"8","author":"McKinley","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0915","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1034\/j.1600-0412.2001.d01-462.x","article-title":"Medical abortion at 57\u00a0to 63\u00a0days\u2019 gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial","volume":"80","author":"World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0920","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0010-7824(99)00119-5","article-title":"Low-dose mifepristone followed by vaginal misoprostol at 48hours for abortion up to 63\u00a0days","volume":"61","author":"Schaff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0925","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0930","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":"Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial","volume":"117","author":"von Hertzen","year":"2010","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0935","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/AOG.0000000000000910","article-title":"Medical compared with surgical abortion for effective pregnancy termination in the first trimester","volume":"126","author":"Ireland","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0940","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/humrep\/deq037","article-title":"Home self-administration of vaginal misoprostol for medical abortion at 50\u201363\u00a0days compared with gestation of below 50\u00a0days","volume":"25","author":"Kopp Kallner","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0945","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2005.11.001","article-title":"Consistency of medical abortion efficacy from 5\u00a0through 14\u00a0weeks\u2019 gestation","volume":"129","author":"Garbin","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0950","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13625187.2011.555568","article-title":"Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70\u00a0days of amenorrhoea in a general practice in Cura\u00e7ao","volume":"16","author":"Boersma","year":"2011","journal-title":"Eur J Contracept Reprod"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0955","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2006.03.016","article-title":"Mifepristone and misoprostol sequential regimen side effects, complications and safety","volume":"74","author":"Sitruk-Ware","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2016.09.033_bib0960","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1432-1033.1994.00651.x","article-title":"Effects of mifepristone (RU-486) on heme metabolism and cytochromes P-450\u00a0in cultured chick embryo liver cells, possible implications for acute porphyria","volume":"225","author":"Cable","year":"1994","journal-title":"Eur J Biochem FEBS"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231516301624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231516301624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T03:43:13Z","timestamp":1601178193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231516301624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":192,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0368231516301624"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2016.09.033","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interruption volontaire de grossesse par voie m\u00e9dicamenteuse","name":"articletitle","label":"Article Title"},{"value":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgyn.2016.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}